Print

Galectin Therapeutics Executive Chairman, James Czirr to Appear on "The RedChip Money Report" on FOX Business News  
2/8/2013 9:44:20 AM

NORCROSS, Ga.--(BUSINESS WIRE)--James Czirr, Executive Chairman of Galectin Therapeutics (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, will be a guest on “The RedChip Money Report”™ television program featuring emerging growth companies on FOX Business News, Saturday, February 9, 2013 at 2:30 p.m. Eastern.
//-->